Crinetics Pharmaceuticals, Inc. · NASDAQ:CRNX

Dapice Joshua J. reported a 6.00% stake in Crinetics Pharmaceuticals, Inc. (Schedule 13G)

Event Aug 29, 2025 · Filed Sep 8, 2025

Dapice Joshua J. reported a 6.00% stake in Crinetics Pharmaceuticals, Inc., 5,625,098 shares, as a passive investor on Aug 29, 2025. Filed Sep 8, 2025 (Schedule 13G).

Stake
6.00%
Shares
5,625,098
Intent
Passive
What changed
Crossed above 5%
Filed together
30 holders

The filing in full

HolderStakeShares
Farallon Capital Partners, L.P.0.40%397,728
Farallon Capital Institutional Partners, L.P.0.50%512,807
Farallon Capital Institutional Partners II, L.P.0.10%123,290
Farallon Capital Institutional Partners III, L.P.0.10%67,865
Four Crossings Institutional Partners V, L.P.0.10%92,559
Farallon Capital Offshore Investors II, L.P.1.00%928,042
Farallon Capital (AM) Investors, L.P.0.10%55,239
Farallon Capital F5 Master I, L.P.0.20%142,177
Farallon Healthcare Partners Master, L.P.3.50%3,305,391
Farallon Partners, L.L.C.5.80%5,482,921
Farallon Institutional (GP) V, L.L.C.0.10%92,559
Farallon F5 (GP), L.L.C.0.20%142,177
Farallon Healthcare Partners (GP), L.L.C.3.50%3,305,391
Dapice Joshua J.6.00%5,625,098
Dreyfuss, Philip D.6.00%5,625,098
Dunn Hannah E.6.00%5,625,098
Fried, Richard B6.00%5,625,098
Gehani, Varun N.6.00%5,625,098
Giauque, Nicolas6.00%5,625,098
Kim, David T.6.00%5,625,098
Linn, Michael G.6.00%5,625,098
Luo Patrick (Cheng)6.00%5,625,098
Patel, Rajiv A.6.00%5,625,098
Roberts, Jr., Thomas G.6.00%5,625,098
Saito Edric C.6.00%5,625,098
Seybold, William6.00%5,625,098
Short Daniel S.6.00%5,625,098
Spokes, Andrew J. M.6.00%5,625,098
Warren, John R.6.00%5,625,098
Wehrly, Mark C.6.00%5,625,098

Source

View original at SEC

Related